What are ANI Pharmaceuticals's profit margins?

ANI Pharmaceuticals (ANIP) runs a 60.8% gross margin and a 13.4% operating margin, with a 10.0% net margin.

Where do ANI Pharmaceuticals's ratios come from?

Every ratio is computed from ANI Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

ANI Pharmaceuticals ANIP Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	61.4%+2.1pp	59.3%-3.4pp	62.7%+6.6pp	56.1%+2.7pp
Operating margin	12.6%—	——	9.6%+21.4pp	-11.7%+6.7pp
Net margin	8.9%+11.9pp	-3%-6.9pp	3.9%+19.0pp	-15.1%+4.6pp
Returns
Return on equity	16.6%+21.0pp	-4.4%-9.5pp	5%+19.8pp	-14.8%+1.3pp
Return on invested capital	15.7%+18.4pp	-2.7%-11.7pp	8.9%+15.9pp	-7%+2.0pp
Efficiency
Asset turnover	0.6×+0.1×	0.6×0.0×	0.6×+0.2×	0.4×+0.1×
Liquidity
Current ratio	2.7×0.0×	2.7×-0.9×	3.6×+0.1×	3.5×-0.2×
Leverage
Debt-to-equity	0.6×-0.2×	0.8×+0.1×	0.7×-0.2×	0.9×+0.1×
Net debt / EBITDA	0.2×-3.2×	3.4×+2.7×	0.7×-11.2×	11.8×-12.7×
Per Share
Book value per share	$25.47+21.9%	$20.90-12.1%	$23.79+23.3%	$19.29-27.2%
Valuation
Market capitalization	$1.77B+52.6%	$1.16B+3.2%	$1.13B+60.4%	$702.17M-8.6%
Price / earnings	22.6×—	——	60×—	——
Price / sales	2×+0.1×	1.9×-0.4×	2.3×+0.1×	2.2×-1.3×
Price / book	3.3×+0.4×	2.9×+0.3×	2.6×+0.4×	2.2×-0.1×
EV / EBITDA	8.9×-16.4×	25.4×+14.2×	11.2×-36.0×	47.2×-80.4×
Dividend yield	0.1%-0.1pp	0.1%0.0pp	0.1%-0.1pp	0.2%+0.2pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about ANI Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are ANI Pharmaceuticals's profit margins?: ANI Pharmaceuticals (ANIP) runs a 60.8% gross margin and a 13.4% operating margin, with a 10.0% net margin.
Where do ANI Pharmaceuticals's ratios come from?: Every ratio is computed from ANI Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.